scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Patrick Kobina Arthur | Q55112172 |
Vincent Amarh | Q63494520 | ||
P2093 | author name string | Patrick K Arthur | |
Vincent Amarh | |||
Amarh, V. | |||
P2860 | cites work | After 30 years of study, the bacterial SOS response still surprises us | Q21092806 |
SOS response induces persistence to fluoroquinolones in Escherichia coli | Q21144990 | ||
New treatment options against gram-negative organisms | Q21194906 | ||
Biochemistry of homologous recombination in Escherichia coli | Q24634614 | ||
RecBCD enzyme and the repair of double-stranded DNA breaks | Q24650931 | ||
Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance | Q27664216 | ||
The double-strand-break repair model for recombination | Q28267259 | ||
How RecBCD enzyme and Chi promote DNA break repair and recombination: a molecular biologist's view | Q28268622 | ||
Rifamycin-mode of action, resistance, and biosynthesis | Q28306550 | ||
RecA protein: structure, function, and role in recombinational DNA repair | Q30427530 | ||
An end-joining repair mechanism in Escherichia coli | Q33719661 | ||
Mode of action of fluoroquinolones | Q33770059 | ||
Spontaneous DNA breakage in single living Escherichia coli cells | Q33796363 | ||
How antibiotics kill bacteria: from targets to networks | Q33958766 | ||
Mycobacteria exploit three genetically distinct DNA double-strand break repair pathways | Q34158258 | ||
Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. | Q34177418 | ||
Mechanisms of action of antimicrobials: focus on fluoroquinolones | Q34183520 | ||
Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde | Q34187326 | ||
The antibiotic resistance crisis: part 1: causes and threats | Q34471028 | ||
Error-Prone Repair of DNA Double-Strand Breaks | Q34478858 | ||
The natural history of antibiotics | Q34986016 | ||
Non-homologous end-joining: bacteria join the chromosome breakdance | Q35063174 | ||
Something old, something new: revisiting natural products in antibiotic drug discovery | Q35109342 | ||
Versatility of aminoglycosides and prospects for their future | Q35176271 | ||
Branch migration prevents DNA loss during double-strand break repair | Q35221144 | ||
Targets for Combating the Evolution of Acquired Antibiotic Resistance | Q35754447 | ||
Role of DNA repair by nonhomologous-end joining in Bacillus subtilis spore resistance to extreme dryness, mono- and polychromatic UV, and ionizing radiation | Q35759710 | ||
Mechanisms of resistance to quinolones | Q36155441 | ||
DNA repair and genome maintenance in Bacillus subtilis | Q36194928 | ||
Mechanisms of drug resistance: quinolone resistance | Q36225422 | ||
Global fluoroquinolone resistance epidemiology and implictions for clinical use. | Q36337074 | ||
Xenobiotics shape the physiology and gene expression of the active human gut microbiome | Q36554412 | ||
New antibiotic agents in the pipeline and how they can help overcome microbial resistance | Q36845895 | ||
Quinolone-mediated bacterial death. | Q36921143 | ||
Double-strand break repair in bacteria: a view from Bacillus subtilis | Q37868655 | ||
Early steps of double-strand break repair in Bacillus subtilis. | Q38079073 | ||
Strategies for the Discovery and Development of New Antibiotics from Natural Products: Three Case Studies. | Q38980013 | ||
The mechanism of the irreversible antimicrobial effects of penicillins: how the beta-lactam antibiotics kill and lyse bacteria | Q39279622 | ||
Correlation of quinolone MIC and inhibition of DNA, RNA, and protein synthesis and induction of the SOS response in Escherichia coli. | Q39817311 | ||
Bactericidal activities of five quinolones for Escherichia coli strains with mutations in genes encoding the SOS response or cell division | Q39871693 | ||
Mechanism of Action of Nalidixic Acid on Escherichia coli III. Conditions Required for Lethality | Q40434882 | ||
Two alternative pathways of double-strand break repair that are kinetically separable and independently modulated | Q40678286 | ||
The multifaceted roles of antibiotics and antibiotic resistance in nature | Q41249257 | ||
The bactericidal activity of DR-3355, an optically active isomer of ofloxacin | Q44861469 | ||
Homologous pairing and DNA strand-exchange proteins. | Q45944296 | ||
Discovery and Total Synthesis of Natural Cystobactamid Derivatives with Superior Activity against Gram-Negative Pathogens. | Q48089588 | ||
DNA gyrase and topoisomerase IV: biochemical activities, physiological roles during chromosome replication, and drug sensitivities | Q50129292 | ||
NHEJ protects mycobacteria in stationary phase against the harmful effects of desiccation. | Q50693569 | ||
Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design. | Q52640613 | ||
Protein- and RNA-synthesis independent bactericidal activity of ciprofloxacin that involves the A subunit of DNA gyrase | Q54308976 | ||
SbcCD causes a double-strand break at a DNA palindrome in the Escherichia coli chromosome. | Q54425189 | ||
Morphological and biochemical changes in Escherichia coli after exposure to ciprofloxacin. | Q54773512 | ||
Control of crossing over | Q64388320 | ||
Conditions required for the bactericidal activity of fleroxacin and pefloxacin against Escherichia coli KL 16 | Q67661696 | ||
Function of the SOS Process in Repair of DNA Damage Induced by Modern 4-Quinolones | Q72098455 | ||
Mechanisms of recombination: lessons from E. coli | Q82640171 | ||
P433 | issue | 8 | |
P921 | main subject | chemotherapy | Q974135 |
DNA double-strand break repair | Q33757109 | ||
Microchips for cell-based assays. | Q37391418 | ||
Problems of antibiotic incompatibility and combination chemotherapy | Q66964562 | ||
P304 | page(s) | FSO411 | |
P577 | publication date | 2019-01-01 | |
2019-09-02 | |||
P1433 | published in | Future science OA | Q27726739 |
P1476 | title | DNA double-strand break formation and repair as targets for novel antibiotic combination chemotherapy | |
P478 | volume | 5 |
Search more.